Glaxosmithkline Pharmaceuticals consolidated net profit rises 167.09% in the September 2021 quarter

Sales rise 14.85% to Rs 1009.87 crore

Net profit of Glaxosmithkline Pharmaceuticals rose 167.09% to Rs 204.24 crore in the quarter ended September 2021 as against Rs 76.47 crore during the previous quarter ended September 2020. Sales rose 14.85% to Rs 1009.87 crore in the quarter ended September 2021 as against Rs 879.32 crore during the previous quarter ended September 2020. ParticularsQuarter EndedSep. 2021Sep. 2020% Var.Sales1009.87879.32 15 OPM %27.3823.30 -PBDT291.14213.02 37 PBT273.54191.06 43 NP204.2476.47 167

Powered by Capital Market - Live News